# Brigham and Women's Hospital RDRC – FDA Inspection, Sep 19, 2019

Source: https://www.keypedia.com/records/fda_inspections/brigham-and-womens-hospital-rdrc/06a20886-73e1-4024-a4b9-966a2452f908
Source feed: FDA_Inspections

> FDA inspection 1102461 of Brigham and Women's Hospital RDRC, September 19, 2019. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 361. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102461
- Company Name: Brigham and Women's Hospital RDRC
- Inspection Date: 2019-09-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Officers

- [Company Rep](https://www.keypedia.com/people/geoffrey-k-kilili/b00aeedf-95bd-4ccf-a23e-6e12e60249c4)

Company: https://www.keypedia.com/companies/brigham-and-womens-hospital-rdrc/fb2e3fce-59df-4f4c-89f2-e1570433b874

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c